English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The Medicines Company
Nicholas Gueguen
| Aug 22, 2017
The Medicines Company releases progress report for second quarter
Nicholas Gueguen
| Jul 22, 2017
ORION-1 Phase II data shows promise for inclisiran
Caitlin Nordahl
| Apr 22, 2017
The Medicines Company to highlight its antimicrobial products at conference in Austria
Gene Johnson
| Apr 10, 2017
Medicines Co. webcast highlights clinical trial results of cholesterol-lowering drug
Kyle Perrotti
| Mar 15, 2017
Conference call to review study of inclisiran
Gene Johnson
| Mar 10, 2017
FDA accepts The Medicines Co.'s filing for urinary tract infection drug
Erianne Leatherman
| Mar 3, 2017
FDA accepts priority application for urinary tract infection treatment
Keri Carbaugh
| Jan 10, 2017
Meanwell presents at Morgan Healthcare Conference
Trending
+
Technology/Innovation
Patient Daily
| May 8, 2025
Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+
Technology/Innovation
Patient Daily
| May 7, 2025
OTO Forum 2025 highlights innovation in ENT
+
Pharmaceuticals
Patient Daily
| May 8, 2025
Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+
Regulatory
Patient Daily
| May 12, 2025
Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'
